Anti-obesity jabs could reduce the risk of heart attacks, strokes or heart failure in obese people regardless of the amount ...
Those taking the drugs for at least three years cut their risk of heart attack, stroke or cardiac death by 20 per cent ...
Ozempic could dramatically reduce the risk of heart attacks and stroke, a new study indicates. The weight loss jab has become ...
Patients taking semaglutide had a 20% lower risk of heart attack, stroke or death due to cardiovascular disease after three ...
Obesity jabs could cut the risk of heart attacks and strokes in people even if they fail to lose much weight, according to an ...
Semaglutide, also known as Ozempic or Wegovy, is set to transform treatments for cardiovascular disease, but a change in ...
New analyses of a large trial presented at the European Congress on Obesity showed the clear benefits of the popular ...
Semaglutide, known by its brand name Wegovy, has become a popular weight loss tool. Here’s how it works, and the risks to ...
Celebrity nutritionist Rose Ferguson has revealed more of her clients have been 'freaking out' about developing so-called ...
Global obesity rates have nearly tripled since 1975, per WHO and Goldman Sachs. The growing usage of GLP-1 drugs in weight ...
Share on Pinterest Researchers say weight-loss medications such as Ozempic can help with heart health as well as long-term ...